Prevención y control de enfermedades no transmisibles y COVID-19

1.WHO. The Thirteenth General Programme of Work, 2019–2023. World Health Organization, Geneva2019

2.Kluge H. A new vision for WHO's European Region: united action for better health. Lancet Public Health. 2020; 5: e133-e134

3.WHO Noncommunicable diseases country profiles 2018. World Health Organization, Geneva2018

4.WHO. 
Overweight. European Health Information Gateway. https://gateway.euro.who.int/en/indicators/h2020_6-overweight/visualizations/#id=17077

5.Wang B Li R Lu Z Huang Y. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging (Albany NY). 2020; 12: 6049-6057

6.WHO. Noncommunicable diseases in emergencies. World Health Organization, Geneva2016

7.Istituto Superiore di Sanità. Characteristics of SARS-CoV-2 patients dying in Italy. Report based on available data on April 29, 2020. COVID-19. https://www.epicentro.iss.it/en/coronavirus/bollettino/Report-COVID-2019_29_april_2020.pdf
Date: 2020

8.Instituto de Salud Carlos III. Informe COVID-19 n° 28. 04 de mayo de 2020. Informe sobre la situación de COVID-19 en España. https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/EnfermedadesTransmisibles/Paginas/InformesCOVID-19.aspx

9.Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)—China, 2020. China CDC Weekly. 2020; 2: 113-122